DR ABDUL GHAFUR

DR ABDUL GHAFUR


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Journal of Global Antimicrobial Resistance
Verified
Journal Article
Closed access
DGDR ABDUL GHAFUR
DR ABDUL GHAFUR
CSChaitra Shankar
Chaitra Shankar
PGPalani GnanaSoundari
Palani GnanaSoundari
MVManigandan Venkatesan
Manigandan Venkatesan
DMDeepa Mani
Deepa Mani
BVBalaji Veeraraghavan
Balaji Veeraraghavan

1 October 2013 in South Asian Journal of Cancer
Verified
Journal Article
Open access
PDF file
DGDR ABDUL GHAFUR
DR ABDUL GHAFUR
PVP. R. Vidyalakshmi
P. R. Vidyalakshmi
KPK. Priyadarshini
K. Priyadarshini
JEJose M. Easow
Jose M. Easow
RRRevathi Raj
Revathi Raj
TRT. Raja
T. Raja
Background: Although Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) infections in immunocompromised hosts have been recognised, clinical data detailing these infections remain limited, especially from India. Antimicrobial susceptibility data on E. meningoseptica remain very limited, with no established breakpoints by Clinical and Laboratory Standards Institute (CLSI). The organism is usually multidrug resistant to antibiotics usually prescribed for treating Gram-negative bacterial infections, a serious challenge to the patient and the treating clinicians. Materials and Methods: The analysis was done in a tertiary care oncology and stem cell transplant center. Susceptibility testing and identification of E. meningoseptica was done using Vitek auto analyzer. Records of immunocompromised patients with E. meningoseptica bacteremia were analysed from January 2009 to March 2012. Results: A total of 29 E. meningoseptica bacteremia cases were documented between 2009 and 2012. Eleven patients were immunocompromised. Three were post stem cell transplant and one was post cord blood transplant. The mean age of the patients was 48.4 years. Mean Charlson’s comorbidity index was 5.7. Four had solid organ malignancies, five had hematological malignancies, and two had lymphoreticular malignancy. Eight patients had received chemotherapy. Mean Apache II score was 18. Mean Pitts score for bacteremia was 4.7. Two were neutropenic (one post SCT, one MDS post chemo) with a mean white blood cell (WBC) count of 450/mm3. Ten had a line at the time of bacteremia. Mean duration of the line prior to bacteremia was 8 days. Eight had line-related bacteremia. Three had pneumonia with secondary bacteremia. All received combination therapy with two or more antibiotics which included cotrimoxazole, rifampicin, piperacillin–tazobactam, tigecycline, or cefepime–tazobactam. All the isolates showed in vitro resistance to ciprofloxacin. Five patients died, but a multivariate analysis was not done to calculate the attributable mortality. Conclusion: In our study, central line was the commonest risk factor for E. meningosepticum bacteremia, although a multivariate analysis was not done. There has not been much of a change in the susceptibility pattern of these organisms over 3 years, with good susceptibility to piperacillin–tazobactam and cotrimoxazole. Even though uncommon, E. meningoseptica is an important pathogen, especially in immunocompromised hosts with indwelling devices.

9 June 2022 in Indian Journal of Medical Microbiology
Verified
Journal Article
Closed access
NANasheed Arum
Nasheed Arum
DGDR ABDUL GHAFUR
DR ABDUL GHAFUR
MKMubin Kazi
Mubin Kazi
RRRatna Rao
Ratna Rao
CRCamilla Rodrigues
Camilla Rodrigues
MTM.A. Thirunarayanan
M.A. Thirunarayanan

10 January 2013 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
DGDR ABDUL GHAFUR
DR ABDUL GHAFUR
To the Editor—Hospitals in the Indian subcontinent have reported very high antimicrobial resistance rates. India, being the most populated country in the region, can play a significant role in tackling antimicrobial resistance initiatives. The Indian medical community has always been responsive to emergent public health problems. Unfortunately, antimicrobial resistance has not been considered a priority for discussion or action, for many reasons. These include a lack of awareness of the enormous adverse clinical and economic impacts of these infections; the relative lack of engagement by prescribing clinicians with Indian microbiologists, who mostly confine themselves to the laboratory; the absence of clinical pharmacists who support good-quality prescribing; and the desire for clinicians to only be concerned with good clinical outcomes for individual patients, regardless of their commitment to the broader public good. However, there may be some light at the end of this rather challenging tunnel. Recent extensive coverage of antibiotic resistance in the mass media and medical journals has made clinicians very concerned about the potential negative outcomes for their patients, leading to a significant positive change in their attitude towards infection control practices. Hospital managements also started recognizing the importance of having an infection control team and are more cooperative in listening to the recommendations of their infection control nurses and doctors. When it comes to prescribing antibiotics prudently, however, there appears to be much less progress.

1 May 2020 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
GPGnana Soundari Palani
Gnana Soundari Palani
DGDR ABDUL GHAFUR
DR ABDUL GHAFUR
PKPadma Krishnan
Padma Krishnan
BRB. Rayvathy
B. Rayvathy
MTMa Thirunarayan
Ma Thirunarayan

1 January 2012 in Antimicrobial Resistance & Infection Control
Verified
Journal Article
Open access
PDF file
DGDR ABDUL GHAFUR
DR ABDUL GHAFUR
VNV Nagvekar
V Nagvekar
STS Thilakavathy
S Thilakavathy
KCK Chandra
K Chandra
RGR Gopalakrishnan
R Gopalakrishnan
CHChennai Apollo Speciality Hospital
Chennai Apollo Speciality Hospital
Carbapenem resistant Enterobacteriaceae is a worldwide threat, with increasing prevalence in many countries. Restricted usage of higher end antibiotics, especially carbapenem is of great importance in tackling these super bugs. Purpose of this retrospective study was to analyse the impact of antibiotic stewardship activities on the prevalence of carbapenem resistant Enterobacteriaceae in our hospital.